Investor Relations We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Neoleukin Therapeutics, Inc's financial performance into perspective. Press Releases September 22, 2023 Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split July 18, 2023 Neurogene and Neoleukin Announce Definitive Merger Agreement March 8, 2023 Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition View all press releases » Events Neurogene and Neoleukin Definitive Merger Agreement Conference Call July 18, 2023 at 8:30 AM EDT View Webcast Canaccord Genuity 42nd Annual Growth Conference August 10, 2022 at 1:00 PM EDT View Webcast View all events & presentations » Corporate Presentations More presentations coming soon.
March 8, 2023 Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition
Neurogene and Neoleukin Definitive Merger Agreement Conference Call July 18, 2023 at 8:30 AM EDT View Webcast